Kutatási jelek – Signal Engine

• UCSF Prostate Cancer Trial: PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer — Prostate cancer
• Hepatic Arterial Infusion Pump Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma — Cholangiocarcinoma
• Triggering cell death in metastatic melanoma may pave the way for new cancer treatments — Melanoma
• Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies — Adenoid cystic carcinoma
• Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck — Head and neck squamous cell carcinoma
• Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial at the 14th Annual Acute Leukemia Meeting — Acute myeloid leukemia
• Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group. — Hodgkin lymphoma
• Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era — Hodgkin lymphoma
• New directions in metastatic mutated NSCLC — NSCLC
• Beat Childhood Cancer Research Consortium at Penn State College of Medicine and Aminex Therapeutics Announce National Clinical Trial for Pediatric Patients with High‑Risk Cancers — Neuroblastoma
• ESMO 2025: Efficacy of Cabozantinib and Nivolumab in Cluster 1/2 Metastatic Clear Cell Renal Cell Carcinoma: Results from OPTIC RCC, a Phase II Trial of a Novel RNAseq-based Biomarker — Renal cell carcinoma
• Merck Announces Phase 3 KEYNOTE‑B96 Trial Met Secondary Endpoint of Overall Survival (OS) in All Comers Population of Patients With Platinum‑Resistant Recurrent Ovarian Cancer — Ovarian cancer
• Clinical Trials — Chronic lymphocytic leukemia
• Ewing Sarcoma Treatment — Leiomyosarcoma
• Iberdomide Shows Promising Phase 3 Results in R/R Multiple Myeloma — Multiple myeloma
• To Study Treatment Resistance in High-Grade Serous Ovarian Cancer, MSK Researchers Develop New Approach — Ovarian cancer
• Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials — Merkel cell carcinoma
• Merkel Cell Carcinoma: Evolving Therapeutics, Continued Challenges — Merkel cell carcinoma
• Merkel Cell Carcinoma in Solid Organ Transplant Recipients: Prognosis and Response to Immunotherapy — Merkel cell carcinoma
• MSK Kids: Recent Research Advances for High-Risk Neuroblastoma | Memorial Sloan Kettering Cancer Center — Neuroblastoma